Wen Shi

1.2k citations
77 papers · 528 indexed · h-index 12
Topics
Ferroptosis and cancer prognosis (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)Cancer-related molecular mechanisms research (4 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
ChinaUnited StatesSpain

In The Last Decade

Wen Shi

69 papers receiving 518 citations

Peers

Wen Shi
Comparison fields: 5 of 124
  • Oncology 161
  • Molecular Biology 149
  • Pulmonary and Respiratory Medicine 111
  • Immunology 65
  • Cancer Research 58
Replace Pang Yao with:
Pang Yao China
Ciro Maiello Italy
Arda Işık Türkiye
Bo Fan China
Dandan Zhang China
Jiahao Xu China
Chunting Wang China
David Schumacher Germany
Seunghyun Lee South Korea
Qiufeng He China
Wen Shi relative to Pang Yao China Pang Yao's profile →
Citations per field
00.5×1.5×2.2×
Pang Yao · 1×
Citations per year

Countries citing papers authored by Wen Shi

Since Specialization
Citations

This map shows the geographic impact of Wen Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Shi more than expected).

Fields of papers citing papers by Wen Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Shi. The network helps show where Wen Shi may publish in the future.

Co-authorship network of co-authors of Wen Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Shi. A scholar is included among the top collaborators of Wen Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Shi. Wen Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 2
4 0
5 1
6 24
7 6
8 2
9 13
10 2
11 4
12 11
13 19
14 4
15 14
16
Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients
6
17 14
18 76
19 2
20 1

About Wen Shi

Wen Shi is a scholar working on Health Informatics, Molecular Medicine and Oncology, having authored 77 papers that have together received 528 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Oncology (161 citations), Health Informatics (7 citations) and Cancer Research (58 citations). Wen Shi has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Yang Jiao, Aiming Yang, Qiong Wang, Yingyun Yang, Dong Wu, Peiqing Sun, Shuang Yang, Yang Ou, Guorong Chen and Wen Yi. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026